Currently, this possibility is being investigated in B-cell acute lymphoblastic leukemia lacking CD19 expression or after failure of anti-CD19 CAR-T cells (clinicaltrials.gov). The gene discussed is CD19; the disease is B-cell acute lymphoblastic leukemia.